NEW YORK, NY — As October marks Breast Cancer Awareness Month, the public conversation is frequently dominated by messages of early detection, mammogram screenings, and the celebration of "survivorship." While these initiatives are vital, they often inadvertently leave behind a segment of the patient population for whom "early detection" is a concept of the past: those living with metastatic breast cancer (MBC).
On October 13, National Metastatic Breast Cancer Awareness Day, the nonprofit organization METAvivor Research and Support will spearhead #LightUpMBC, a massive global initiative designed to pull the terminal realities of Stage 4 breast cancer out of the shadows. By illuminating more than 325 landmarks across 20 countries in the signature colors of teal, green, and pink, the campaign seeks to transform passive awareness into aggressive, research-focused action.
The Reality of Stage 4: Defining the "Invisible" Crisis
Metastatic breast cancer occurs when cancer cells migrate from the breast to distant organs, most commonly the bones, liver, lungs, or brain. It is crucial to understand that even when the cancer is found in another organ, it remains breast cancer. It is not "bone cancer" or "lung cancer"; it is metastatic breast cancer.
For many, the diagnosis comes as a shock—Stage 4 from the very outset. For others, it is a devastating recurrence, surfacing months, years, or even decades after the successful treatment of an earlier stage of the disease. Unlike early-stage breast cancer, which focuses on eradication, the clinical goal for MBC is palliative: to control the spread, extend life, and preserve quality of life.
The medical reality is stark. MBC is currently incurable. Patients face a lifelong cycle of treatments, shifting therapies as the cancer develops resistance. According to data from the National Cancer Institute (SEER), an estimated 42,670 people in the United States are expected to lose their lives to breast cancer in 2026 alone—a staggering figure that translates to approximately 117 deaths every single day. This statistic underscores the urgent, unmet need for transformative research.
Chronology of a Movement: From Local Tribute to Global Beacon
The origins of #LightUpMBC are deeply personal, rooted in the grief and resolve of a singular friendship. The campaign was founded by Laura Inahara, who sought to honor her best friend, Jessica Moore. Moore, who passed away from metastatic breast cancer at the age of 36, harbored a simple, poignant wish: to see a local landmark illuminated to bring visibility to the disease that was consuming her life.
What began as a localized effort to light a single structure has blossomed into a logistical and emotional juggernaut.
- 2017: The movement saw its first milestone when Portsmouth’s Memorial Bridge in New Hampshire was illuminated in the colors of MBC.
- 2020-2025: As the awareness of Stage 4 disease grew, the campaign expanded rapidly across the United States and internationally, gaining the support of municipal governments and landmark authorities.
- 2026: The campaign now spans 50 U.S. states, 195 cities, and 20 countries. Iconic structures, including One World Trade Center in New York City, the Willis Tower in Chicago, Philadelphia City Hall, Niagara Falls, and the Ness Bridge in Scotland, are slated to participate.
The campaign has successfully raised over $2.7 million for critical research to date, proving that localized advocacy can catalyze significant scientific funding.
Supporting Data: Why Research is the Only Pathway Forward
METAvivor remains the only organization that exclusively funds Stage 4 metastatic breast cancer research. Because MBC research has historically been underfunded compared to early-stage cancer studies, METAvivor’s role is critical in filling the gap.
The organization employs a rigorous, two-tiered review process. Each grant proposal undergoes:
- Scientific Peer Review: Evaluated by leading oncology researchers to ensure the study is scientifically sound and holds promise for clinical application.
- Patient Advocate Review: Evaluated by individuals living with MBC to ensure the research addresses the real-world needs of the patient population—specifically regarding quality of life and survival rates.
This dual-vetting process ensures that every dollar donated is funneled toward projects with the highest potential to transition MBC from a terminal diagnosis into a manageable, chronic, or potentially curable condition.
Voices from the Frontlines: Official Responses
The leadership behind METAvivor and the #LightUpMBC campaign are not merely administrators; they are advocates who live within the shadow of the disease.
Dr. Kelly Shanahan, Board President of METAvivor, was diagnosed with metastatic breast cancer in 2013. Reflecting on her journey, she noted, "When I was diagnosed, I certainly didn’t think I’d still be here 13 years later. My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days, and #LightUpMBC serves as both the biggest contributor to this research and a powerful way to bring us together as a community."
Founder Laura Inahara emphasizes the legacy of the campaign. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has raised millions for critical research."
LightUpMBC Live: The 2026 Broadcast
The centerpiece of the awareness day is the #LightUpMBC Live broadcast, a free, virtual event that bridges the gap between scientific advancement and the human experience. Scheduled for October 13 at 8:00 p.m. ET / 5:00 p.m. PT, the event will be hosted by Tami Eagle Bowling—who has lived with MBC for 11 years—and Broadway performer and breast cancer survivor Kara Lindsay.
The broadcast will feature:
- Patient Stories: Live testimonials from individuals standing at illuminated landmarks across the globe.
- Scientific Briefings: Updates from researchers on the latest breakthroughs in targeted therapies and clinical trials.
- Musical Performances: A curated program featuring two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, singer-songwriter Cassandra Kubinski, and legendary voiceover artist Tony Daniels.
The event will be streamed on the METAvivor YouTube channel, Facebook Live, and via the LiveOne platform. Organizers emphasize that 100% of net proceeds from the campaign and the live stream will go directly to funding Stage 4 research.
Implications: Changing the Narrative
The broader implication of #LightUpMBC is a fundamental shift in how society views "survivorship." For years, the pink ribbon culture focused almost exclusively on the "warrior" narrative—the idea that if you fight hard enough, you will be cured. For the metastatic community, this narrative can be isolating and harmful.
By shifting the conversation toward the reality of Stage 4, #LightUpMBC creates space for the nuances of living with a terminal, yet treatable, condition. It challenges the medical community to prioritize research that doesn’t just stop at early detection but pushes into the complex biology of metastasis.
As the sun sets on October 13, the glowing landmarks will serve as more than just a visual spectacle. They will function as a global, luminous petition for life. They represent the collective refusal of patients, researchers, and families to accept the status quo.
For those wishing to participate, the call to action is simple:
- Visit: Go to www.lightupmbc.org to see a list of participating landmarks and donate.
- Engage: Photograph the illuminated landmarks in your area and share them on social media using the hashtags #LightUpMBC and #METAvivor, tagging @LightUpMBC.
- Watch: Tune in to the livestream to hear the stories that define the movement.
In the words of the organizers, the goal is not just to shine a light, but to ensure that one day, the lights will stay on for every patient, signifying a victory over a disease that has claimed too many, for too long.
About the Author
